Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
€ 35,82 ↓ -1.80 (-4.78%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionQuadrant Capital Group Llc
Latest Disclosed Ownership60,354 shares
Latest Disclosed Value $ 2,218,043
Quadrant Capital Group Llc reports 36.26% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 13, 2026 - Quadrant Capital Group Llc filed a 13F-HR/A form disclosing ownership of 60,354 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $1,904,169 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 94,683 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -36.26% during the quarter. The current value of the position is $2,161,880 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 NOVO-NORDISK A S ADR 670100205 60,354 -34,329 -36.26 2,218 -53.95 0.0663
2026-05-11 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 60,354 -34,329 49 0.0369
2026-02-12 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 94,683 10,341 12.26 4,817 2.93 0.1455
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 84,342 -36,116 -29.98 4,680 -43.71 0.1521
2025-08-13 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 120,458 12,641 11.72 8,314 11.03 0.2992
2025-05-13 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 107,817 72,424 204.63 7,489 145.99 0.2781
2025-02-13 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 35,393 -2,806 -7.35 3,045 -33.07 0.2096
2024-11-12 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 38,199 1,004 2.70 4,548 -14.33 0.3160
2024-08-12 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 37,195 1,150 3.19 5,309 14.69 0.3942
2024-05-15 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 36,045 1,009 2.88 4,630 27.73 0.3656
2024-02-08 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 35,036 2,347 7.18 3,624 21.94 0.3113
2023-11-14 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 32,689 17,783 119.30 2,973 23.22 0.2976
2023-08-10 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 14,906 -229 -1.51 2,412 0.12 0.2394
2023-05-11 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 15,135 1,110 7.91 2,410 26.92 0.2509
2023-02-13 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 14,025 1,431 11.36 1,898 51.24 0.2151
2022-11-10 2022-09-30 13F NOVO-NORDISK A S ADR 670100205 12,594 207 1.67 1,255 -9.06 0.1660
2022-08-09 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 12,387 985 8.64 1,380 9.00 0.1854
2022-05-06 2022-03-31 13F NOVO-NORDISK A S ADR 670100205 11,402 844 7.99 1,266 7.11 0.1533
2022-02-01 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 10,558 1,074 11.32 1,182 29.75 0.1410
2021-11-12 2021-09-30 13F NOVO-NORDISK A S ADR 670100205 9,484 265 2.87 911 18.01 0.1271
2021-08-09 2021-06-30 13F NOVO-NORDISK A S ADR 670100205 9,219 546 6.30 772 31.97 0.1120
2021-05-12 2021-03-31 13F NOVO-NORDISK A S ADR 670100205 8,673 1,113 14.72 585 10.80 0.0949
2021-02-16 2020-12-31 13F NOVO-NORDISK A S ADR 670100205 7,560 602 8.65 528 9.32 0.0980
2020-11-13 2020-09-30 13F NOVO-NORDISK A S ADR 670100205 6,958 1,332 23.68 483 31.25 0.1053
2020-08-13 2020-06-30 13F NOVO-NORDISK A S ADR 670100205 5,626 -20,107 -78.14 368 -76.30 0.0814
2020-05-15 2020-03-31 13F Novo Nordisk A Com 670100205 25,733 477 1.89 1,553 7.77 0.2600
2020-03-19 2019-12-31 13F/A-1 Novo Nordisk A Com 670100205 25,256 5,506 27.88 1,441 43.10 0.1738
2020-02-03 2019-12-31 13F Novo Nordisk A Com 670100205 25,256 5,506 1,441 4,869.3270
2019-10-24 2019-09-30 13F Novo Nordisk A COM 670100205 19,750 2,372 13.65 1,007 15.22 0.1549
2019-07-24 2019-06-30 13F Novo Nordisk A COM 670100205 17,378 390 2.30 874 0.00 0.1383
2019-04-29 2019-03-31 13F Novo Nordisk A COM 670100205 16,988 4,681 38.04 874 58.62 0.1536
2019-01-17 2018-12-31 13F Novo Nordisk A COM 670100205 12,307 7,099 136.31 551 138.53 0.1469
2018-10-29 2018-09-30 13F Novo Nordisk A COM 670100205 5,208 -55 -1.05 231 0.87 0.0660
2018-08-08 2018-06-30 13F Novo Nordisk A COM 670100205 5,263 116 2.25 229 -5.76 0.0803
2018-05-10 2018-03-31 13F Novo Nordisk A COM 670100205 5,147 0 0.00 243 -7.60 0.0881
2018-01-31 2017-12-31 13F Novo-Nordisk A COM 670100205 5,147 104 2.06 263 13.85 0.1049
2017-10-13 2017-09-30 13F Novo-Nordisk A COM 670100205 5,043 479 10.50 231 32.00 0.0953
2017-08-14 2017-06-30 13F Novo-Nordisk A COM 670100205 4,564 2,086 84.18 175 127.27 0.0774
2017-04-10 2017-03-31 13F Novo-Nordisk A COM 670100205 2,478 117 4.96 77 4.05 0.0338
2017-01-11 2016-12-31 13F Novo-Nordisk A COM 670100205 2,361 1,584 203.86 74 184.62 0.0371
2016-10-25 2016-09-30 13F Novo-Nordisk A COM 670100205 777 -778 -50.03 26 -66.67 0.0170
2016-07-28 2016-06-30 13F Novo-Nordisk A COM 670100205 1,555 44 2.91 78 2.63 0.0537
2016-04-27 2016-03-31 13F Novo-Nordisk A COM 670100205 1,511 -897 -37.25 76 -43.70 0.0492
2016-01-28 2015-12-31 13F Novo-Nordisk A COM 670100205 2,408 -711 -22.80 135 -18.67 0.0934
2015-10-28 2015-09-30 13F Novo-Nordisk A COM 670100205 3,119 345 12.44 166 11.41 0.1145
2015-08-12 2015-06-30 13F Novo-Nordisk A COM 670100205 2,774 2,774 149 0.0948
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.